➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Moodys
AstraZeneca
McKesson
Harvard Business School

Last Updated: May 28, 2020

DrugPatentWatch Database Preview

FLUORESCITE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Fluorescite, and when can generic versions of Fluorescite launch?

Fluorescite is a drug marketed by Alcon Labs Inc and is included in one NDA.

The generic ingredient in FLUORESCITE is fluorescein sodium. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the fluorescein sodium profile page.

Drug patent expirations by year for FLUORESCITE
Recent Clinical Trials for FLUORESCITE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Medicor Research Inc.Phase 1
UpTru Inc.Phase 1
National Heart, Lung, and Blood Institute (NHLBI)Phase 2

See all FLUORESCITE clinical trials

Pharmacology for FLUORESCITE
Drug ClassDiagnostic Dye
Mechanism of ActionDyes
Synonyms for FLUORESCITE
(3H)Xanthen-3-one, 10-deshydro-6-hydroxy-10-[2-carboxyphen-1-yl]-
1flr
1n0s
2-(3-hydroxy-6-keto-xanthen-9-yl)benzoic acid
2-(3-hydroxy-6-oxo-6H-xanthen-9-yl)benzoic acid
2-(6-HYDROXY-3-OXO-3H-XANTHEN-9-YL)-BENZOIC ACID
2-(6-Hydroxy-3-oxo-3H-xanthen-9-yl)benzoesaure
2-(6-Hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid
2-(6-Hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid #
2-(6-hydroxy-3-oxoxanthen-9-yl)benzoic acid
2-(6-oxido-3-oxo-3H-xanthen-9-yl)benzoate
3',6'-Dihydroxy-spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one
3'',6''-dihydroxyspiro[1,3-dihydroisobenzofuran-1,9''-(9''H-xanthene)]-3-one
321H075
3H-Xanthen-3-one, 6-hydroxy-10-[2-carboxyphenyl]-
41935-48-2
518-45-6
93X55PE38X
Ak-Fluor
AKOS000503167
AKOS024364966
ARONIS014456
AS-17142
BBL002034
BDBM50143424
C.I.45350:1
C20H10O5.2Na
CBDivE_002901
CHEMBL1628233
CHEMBL177756
CI 45350
cid_3383
CTK1G3923
D02024
disodium 2-(6-oxido-3-oxo-3H-xanthen-9-yl)benzoate
F0096
Floures (TN)
flourescein
Fluor-I-strip A.T.
Fluorescein sodium (JP17/USP)
Fluorescein sodium [USP:BAN:JAN]
fluorescein, sodium salt
Fluorescein, soluble
fluoresceinnatrium
Fluoresein sodium
Fluoreseptic
FT-0626450
Ful-Glo
Funduscein-25
HSDB 8007
KS-000044VW
MCULE-1559500470
MCULE-8810198732
MOLI001004
NJDNXYGOVLYJHP-UHFFFAOYSA-L
NS-05493
NSC-5070
NSC5070
Q27271622
Q27460338
SBB001359
SCHEMBL107875
SCHEMBL264060
ST009474
STK391288
T217
T7547
TG2-210
UNII-93X55PE38X
Uranin
YKGGGCXBWXHKIZ-UHFFFAOYSA-N
Z1262246141
ZINC3872582

US Patents and Regulatory Information for FLUORESCITE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon Labs Inc FLUORESCITE fluorescein sodium INJECTABLE;INTRAVENOUS 021980-001 Mar 28, 2006 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Moodys
AstraZeneca
McKesson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.